Literature DB >> 26891081

Syndecan-4 Enhances Therapeutic Angiogenesis after Hind Limb Ischemia in Mice with Type 2 Diabetes.

Subhamoy Das1, Anthony J Monteforte1, Gunjan Singh1, Marjan Majid1, Michael B Sherman2, Andrew K Dunn1, Aaron B Baker1,3,4,5.   

Abstract

Delivering syndecan-4 with FGF-2 improves the effectiveness of FGF-2 therapy for ischemia in the diabetic disease state. The syndecan-4 proteoliposomes significantly enhance in vitro tubule formation as well as blood perfusion and vessel density in the ischemic hind limbs of diseased ob/ob mice. Syndecan-4 therapy also induces a marked immunomodulation in the tissues, increasing the polarization of macrophages toward the M2 phenotype.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  fibroblast growth factor-2 (FGF-2); ischemia; peripheral vascular diseases; syndecan-4; therapeutic angiogenesis

Mesh：

Substances：

Year:  2016        PMID： 26891081      PMCID： PMC4864113          DOI： 10.1002/adhm.201500993

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN： 2192-2640            Impact factor:   9.933


  19 in total

1.  Robust flow measurement with multi-exposure speckle imaging.

Authors:  Ashwin B Parthasarathy; W J Tom; Ashwini Gopal; Xiaojing Zhang; Andrew K Dunn
Journal:  Opt Express       Date:  2008-02-04       Impact factor: 3.894

Review 2.  Peripheral artery disease. Part 2: medical and endovascular treatment.

Authors:  Mitchell D Weinberg; Joe F Lau; Kenneth Rosenfield; Jeffrey W Olin
Journal:  Nat Rev Cardiol       Date:  2011-06-14       Impact factor: 32.419

3.  Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial.

Authors:  Y H Kusumanto; V van Weel; N H Mulder; A J Smit; J J A M van den Dungen; J M M Hooymans; W J Sluiter; R A Tio; P H A Quax; R O B Gans; R P F Dullaart; G A P Hospers
Journal:  Hum Gene Ther       Date:  2006-06       Impact factor: 5.695

4.  Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia.

Authors:  H Shigematsu; K Yasuda; T Iwai; T Sasajima; S Ishimaru; Y Ohashi; T Yamaguchi; T Ogihara; R Morishita
Journal:  Gene Ther       Date:  2010-04-15       Impact factor: 5.250

Review 5.  Inflammation and wound healing: the role of the macrophage.

Authors:  Timothy J Koh; Luisa Ann DiPietro
Journal:  Expert Rev Mol Med       Date:  2011-07-11       Impact factor: 5.600

6.  Removal of divalent cations induces structural transitions in red clover necrotic mosaic virus, revealing a potential mechanism for RNA release.

Authors:  Michael B Sherman; Richard H Guenther; Florence Tama; Tim L Sit; Charles L Brooks; Albert M Mikhailov; Elena V Orlova; Timothy S Baker; Steven A Lommel
Journal:  J Virol       Date:  2006-08-18       Impact factor: 5.103

7.  Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia.

Authors:  Sigrid Nikol; Iris Baumgartner; Eric Van Belle; Curt Diehm; Adriana Visoná; Maurizio C Capogrossi; Nicole Ferreira-Maldent; Augusto Gallino; Michael Graham Wyatt; Lasantha Dinesh Wijesinghe; Melissa Fusari; Dominique Stephan; Joseph Emmerich; Giulio Pompilio; Frank Vermassen; Emmanuel Pham; Vincent Grek; Michael Coleman; François Meyer
Journal:  Mol Ther       Date:  2008-04-01       Impact factor: 11.454

8.  ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67.

Authors:  Vilppu J Tuominen; Sanna Ruotoistenmäki; Arttu Viitanen; Mervi Jumppanen; Jorma Isola
Journal:  Breast Cancer Res       Date:  2010-07-27       Impact factor: 6.466

Review 9.  Peripheral arterial disease in patients with diabetes.

Authors:  Steven P Marso; William R Hiatt
Journal:  J Am Coll Cardiol       Date:  2006-02-09       Impact factor: 24.094

10.  Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia.

Authors:  Satoaki Matoba; Tetsuya Tatsumi; Toyoaki Murohara; Tsutomu Imaizumi; Yousuke Katsuda; Masaaki Ito; Yoshihiko Saito; Shiro Uemura; Hiroshi Suzuki; Shinya Fukumoto; Yasutaka Yamamoto; Rie Onodera; Satoshi Teramukai; Masanori Fukushima; Hiroaki Matsubara
Journal:  Am Heart J       Date:  2008-09-19       Impact factor: 4.749
View more
  13 in total

Review 1.  Therapeutic strategies for enhancing angiogenesis in wound healing.

Authors:  Austin P Veith; Kayla Henderson; Adrianne Spencer; Andrew D Sligar; Aaron B Baker
Journal:  Adv Drug Deliv Rev       Date:  2018-09-26       Impact factor: 15.470

2.  * Glioblastoma Exosomes for Therapeutic Angiogenesis in Peripheral Ischemia.

Authors:  Anthony Monteforte; Brian Lam; Michael B Sherman; Kayla Henderson; Andrew D Sligar; Adrianne Spencer; Brian Tang; Andrew K Dunn; Aaron B Baker
Journal:  Tissue Eng Part A       Date:  2017-11       Impact factor: 3.845

3.  A MicroRNA93-Interferon Regulatory Factor-9-Immunoresponsive Gene-1-Itaconic Acid Pathway Modulates M2-Like Macrophage Polarization to Revascularize Ischemic Muscle.

Authors:  Vijay Chaitanya Ganta; Min Hyub Choi; Anna Kutateladze; Todd E Fox; Charles R Farber; Brian H Annex
Journal:  Circulation       Date:  2017-03-29       Impact factor: 29.690

4.  Syndecan-4 regulates the bFGF-induced chemotactic migration of endothelial cells.

Authors:  Ran Li; Han Wu; Jun Xie; Guannan Li; Rong Gu; Lina Kang; Lian Wang; Biao Xu
Journal:  J Mol Histol       Date:  2016-08-19       Impact factor: 2.611

5.  Biomechanical regulation of breast cancer metastasis and progression.

Authors:  Adrianne Spencer; Andrew D Sligar; Daniel Chavarria; Jason Lee; Darshil Choksi; Nikita P Patil; HooWon Lee; Austin P Veith; William J Riley; Shubh Desai; Ali Abbaspour; Rohan Singeetham; Aaron B Baker
Journal:  Sci Rep       Date:  2021-05-10       Impact factor: 4.379

6.  Pathological Angiogenesis Requires Syndecan-4 for Efficient VEGFA-Induced VE-Cadherin Internalization.

Authors:  Giulia De Rossi; Maria Vähätupa; Enrico Cristante; Samantha Arokiasamy; Sidath E Liyanage; Ulrike May; Laura Pellinen; Hannele Uusitalo-Järvinen; James W Bainbridge; Tero A H Järvinen; James R Whiteford
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-02-18       Impact factor: 10.514

Review 7.  Biomaterials and Nanotherapeutics for Enhancing Skin Wound Healing.

Authors:  Subhamoy Das; Aaron B Baker
Journal:  Front Bioeng Biotechnol       Date:  2016-10-31

8.  Cell Density-Dependent Fibroblast Growth Factor-2 Signaling Regulates Syndecan-4 Expression in Cultured Vascular Endothelial Cells.

Authors:  Takato Hara; Shiori Yabushita; Chika Yamamoto; Toshiyuki Kaji
Journal:  Int J Mol Sci       Date:  2020-05-24       Impact factor: 5.923

Review 9.  Syndecan receptors: pericellular regulators in development and inflammatory disease.

Authors:  Sandeep Gopal; Samantha Arokiasamy; Csilla Pataki; James R Whiteford; John R Couchman
Journal:  Open Biol       Date:  2021-02-10       Impact factor: 6.411

Review 10.  Proteoglycans in Biomedicine: Resurgence of an Underexploited Class of ECM Molecules.

Authors:  Tanaya Walimbe; Alyssa Panitch
Journal:  Front Pharmacol       Date:  2020-01-29       Impact factor: 5.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.